June 26, 2016
Recommended Topic Related To:

Zemaira

"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...

A A A

Zemaira




Overdosage
Contraindications

OVERDOSE

No information provided.

CONTRAINDICATIONS

  • Zemaira is contraindicated in patients with a history of anaphylaxis or severe systemic reactions to Zemaira or A1-PI protein.
  • Zemaira is contraindicated in immunoglobulin A (IgA)-deficient patients with antibodies against IgA, due to the risk of severe hypersensitivity [see WARNINGS AND PRECAUTIONS].
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 3/18/2016

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.